A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function
Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess the amount of study drug that reaches the
bloodstream and the time it takes for the body to get rid of it when given to participants
with renal (kidney) impairment compared to healthy participants. The study will last up to 5
weeks, excluding screening.